ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,701 | 67.47998 | 1 | female | 0 | 8 | 266 | Colon Cancer | Cancer | 2 | 11 | null | 0 | 7,020 | 5,177.6289 | null | 11.5 | white | 20.296875 | 23 | 0.761963 | 0.510986 | 1 | 1 | 0 | metastatic | 0.8 | 0.25 | no dnr | 8 | 96 | 6.299805 | 80 | 20 | 37.59375 | null | 2.899902 | 0.5 | 1.5 | 139 | null | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
1,702 | 77.758 | 1 | male | 1 | 15 | 15 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $11-$25k | 9 | 17,610 | 10,376.9688 | null | 18.333328 | white | 36.398438 | 68 | 0.425964 | 0.306946 | 1 | 0 | 0 | no | 0.4 | 0 | dnr after sadm | 7 | 49 | 7.199219 | 94 | 36 | 34.19531 | 320 | 3.599609 | 1.599854 | 6.5 | 136 | 7.429688 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
1,703 | 36.27698 | 0 | female | 0 | 11 | 1,953 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 0 | 20,110 | 8,962.0156 | null | 28 | white | 23.5 | 29 | 0.888916 | 0.848999 | 1 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 11 | 54 | 18.296875 | 76 | 14 | 35.79688 | 195 | 2.799805 | 0.599976 | 0.799927 | 139 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,704 | 80.75 | 0 | male | 0 | 23 | 1,952 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 25,860 | 17,224.5469 | null | 14 | white | 20 | 29 | 0.747925 | 0.668945 | 2 | 1 | 0 | yes | 0.95 | 0.85 | no dnr | 23 | 100 | 11.398438 | 100 | 26 | 37.79688 | 322.5 | 2.899902 | 1.199951 | 1.299805 | 148 | 7.359375 | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
1,705 | 68.323 | 1 | female | 0 | 17 | 223 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 33,471 | 19,604.7969 | null | 14.666664 | white | 21.296875 | 37 | 0.768921 | 0.632935 | 3 | 1 | 0 | yes | 0.9 | 0.8 | no dnr | 17 | 67 | 9.599609 | 122 | 26 | 37.79688 | 227.5 | null | null | 1.099854 | 132 | 7.40918 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,706 | 71.63599 | 0 | female | 0 | 14 | 1,951 | COPD | COPD/CHF/Cirrhosis | 1 | 7 | under $11k | 0 | 10,530 | 7,928.7734 | null | 10.333328 | white | 16.097656 | 40 | 0.875 | 0.791992 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 14 | 63 | 8.699219 | 76 | 30 | 36.29688 | 240 | null | null | 1.199951 | 143 | 7.339844 | null | null | null | 2 | 4 | no(M2 and SIP pres) | 4 |
1,707 | 70.76495 | 1 | male | 0 | 10 | 252 | COPD | COPD/CHF/Cirrhosis | 1 | 11 | $11-$25k | 0 | 8,711 | 6,830.3867 | null | 13 | white | 23.296875 | 24 | 0.791992 | 0.665894 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 10 | 83 | 10.699219 | 108 | 32 | 36.09375 | 188.5625 | null | null | 1 | 141 | 7.359375 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
1,708 | 89.487 | 0 | female | 0 | 3 | 1,950 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 3,584 | 2,357.1133 | null | 14 | white | 18.5 | 22 | 0.740967 | 0.592896 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 3 | 100 | 14.398438 | 86 | 18 | 37.29688 | 200 | null | null | 0.599976 | 138 | 7.329102 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,709 | 55.80298 | 1 | female | 0 | 3 | 221 | COPD | COPD/CHF/Cirrhosis | 0 | 12 | null | 0 | 3,057 | 1,528.8027 | null | 7 | white | 21.796875 | 24 | 0.884888 | 0.807983 | 1 | 0 | 0 | no | 0.8 | 0.5 | dnr after sadm | 2 | 90 | 7.5 | 110 | 25 | 37.59375 | 208 | null | null | 0.5 | 139 | 7.349609 | null | null | null | 4 | 6 | adl>=4 (>=5 if sur) | 6 |
1,710 | 72.59698 | 1 | male | 0 | 14 | 291 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 17,419 | 10,273.3359 | null | 19.666656 | white | 23 | 28 | 0.794922 | 0.727905 | 1 | 0 | 0 | no | 1 | 0.99 | no dnr | 14 | 63 | 4.299805 | 102 | 28 | 37.5 | 365 | 2.799805 | null | 1.699951 | 139 | 7.399414 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
1,711 | 79.62994 | 1 | female | 0 | 12 | 1,398 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 9 | 11,895 | 6,759.8086 | null | 11.5 | white | 25.898438 | 32 | 0.685913 | 0.592896 | 1 | 0 | 1 | no | null | null | dnr after sadm | 1 | 75 | 11.099609 | 101 | 26 | 37.19531 | 141.65625 | null | null | 0.799927 | 147 | 7.139648 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
1,712 | 71.54297 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 0 | 31,316 | 16,828.9375 | null | 29.5 | white | 32.195313 | 55 | 0.412964 | 0.292969 | 5 | 0 | 0 | yes | 0.15 | 0.12 | dnr after sadm | 5 | 60 | 1.299805 | 136 | 32 | 36 | 371.375 | 1.699951 | 0.099991 | 1.799805 | 145 | 7.469727 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
1,713 | 42.78998 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 19,185 | 9,497.8828 | null | 37 | null | 50 | 86 | 0.049995 | 0.015999 | 3 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 49 | 3.899902 | 128 | 28 | 34.5 | 436 | null | 8.5 | 3.899902 | 138 | 7.209961 | null | null | null | null | null | <2 mo. follow-up | 2.518066 |
1,714 | 73.91895 | 1 | female | 0 | 6 | 46 | CHF | COPD/CHF/Cirrhosis | 2 | 7 | under $11k | 0 | 4,780 | 3,638.6152 | null | 10 | white | 18.296875 | 31 | 0.853882 | 0.759888 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 6 | 97 | null | 76 | 24 | 37.69531 | 256.625 | null | null | 2.799805 | 139 | 7.439453 | null | null | null | 1 | 5 | <2 mo. follow-up | 5 |
1,715 | 67.37598 | 0 | male | 0 | 13 | 1,945 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | >$50k | 0 | 21,696 | 18,037.2969 | null | 24 | white | 31.097656 | 59 | 0.671997 | 0.575928 | 1 | 1 | 0 | no | 0.95 | 1 | no dnr | 13 | 75 | 11.5 | 150 | 8 | 38.59375 | 121.65625 | null | 0.899902 | 2 | 134 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,716 | 77.06995 | 1 | female | 0 | 6 | 12 | CHF | COPD/CHF/Cirrhosis | 1 | 10 | null | 0 | 3,634 | 2,929.1738 | null | 9 | white | 16.597656 | 31 | 0.862915 | 0.772949 | 1 | 0 | 0 | no | 0.5 | 0.3 | no dnr | 6 | 117 | 9.5 | 74 | 16 | 36.29688 | null | 4.199219 | 0.5 | 2.899902 | 135 | null | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
1,717 | 72.10095 | 1 | male | 0 | 22 | 56 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 24,014 | 18,220.5156 | null | 17 | white | 28.796875 | 35 | 0.700928 | 0.53894 | 1 | 0 | 0 | no | 0.25 | 0.1 | dnr after sadm | 3 | 70 | 3.299805 | 72 | 20 | 36.29688 | null | 3.199707 | null | 5.299805 | 128 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,718 | 96.422 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 17,637 | 7,842.3086 | null | 26.5 | white | 34.5 | 52 | 0.217987 | 0.120987 | 3 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 8 | 51 | 20.597656 | 80 | 28 | 36.09375 | 250 | 2.799805 | null | 3.099609 | 128 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 4.890625 |
1,719 | 70.034 | 1 | female | 0 | 47 | 1,687 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | $11-$25k | 0 | 69,542 | 49,621.9688 | null | 20.25 | white | 17.199219 | 32 | 0.875977 | 0.793945 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 47 | 111 | 13.099609 | 80 | 32 | 35.89844 | null | 4 | null | 1.599854 | 141 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,720 | 65.51697 | 1 | male | 0 | 6 | 197 | Lung Cancer | Cancer | 2 | null | null | 0 | 8,659 | 6,245.7969 | null | 12 | white | 5.799805 | 16 | 0.868896 | 0.706909 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 6 | 80 | 7.099609 | 86 | 20 | 37.5 | null | 4.199219 | null | 1.299805 | 138 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,721 | 91.67694 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | under $11k | 0 | 14,107 | 5,900.5625 | null | 32 | white | 37.09375 | 55 | 0.265991 | 0.158997 | 1 | 1 | 0 | yes | 0.1 | 0.001 | dnr after sadm | 4 | 46 | 15.099609 | 50 | 26 | 37.69531 | 185 | 3.199707 | 0.699951 | 3.099609 | 136 | 7.289062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,722 | 36.53699 | 0 | male | 0 | 62 | 1,941 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $25-$50k | 0 | 117,256 | 31,268.7656 | null | 28 | white | 20.699219 | 33 | 0.897949 | 0.861938 | 3 | 0 | 0 | no | null | null | no dnr | 62 | 108 | 8.898438 | 110 | 8 | 39.29688 | 202 | 1.899902 | 1.899902 | 1.199951 | 133 | 7.389648 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
1,723 | 81.284 | 0 | female | 0 | 6 | 1,939 | CHF | COPD/CHF/Cirrhosis | 1 | null | >$50k | 0 | 5,025 | 3,666.4121 | null | 8 | white | 15.898438 | 31 | 0.85791 | 0.764893 | 1 | 0 | 0 | no | 0.9 | 0.5 | dnr before sadm | 0 | 105 | 7.899414 | 58 | 28 | 36.29688 | 304.75 | 3.699707 | null | 1 | 142 | 7.489258 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,724 | 71.16498 | 0 | male | 0 | 13 | 1,938 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 9 | 17,918 | 11,141.7109 | null | 16.5 | white | 17.5 | 30 | 0.849976 | 0.797974 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 13 | 73 | 5.799805 | 68 | 27 | 37.79688 | 266.625 | 2.599609 | null | 1.5 | 138 | 7.449219 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,725 | 62.64499 | 1 | female | 0 | 9 | 13 | Colon Cancer | Cancer | 1 | null | null | 0 | 9,016 | 2,677.668 | null | 10 | white | 35.09375 | 32 | 0.425964 | 0.120987 | 1 | 0 | 0 | metastatic | 0.25 | 0.05 | dnr after sadm | 1 | 80 | 8.898438 | 70 | 25 | 37 | null | 2.799805 | 29 | 0.699951 | 142 | null | null | null | null | 7 | 7 | <2 mo. follow-up | 7 |
1,726 | 39.31299 | 0 | female | 0 | 12 | 1,938 | MOSF w/Malig | ARF/MOSF | 1 | 12 | null | 0 | 24,390 | 15,204.3672 | null | 24.5 | white | 29.097656 | 73 | 0.600952 | 0.493958 | 2 | 0 | 0 | yes | null | null | no dnr | 12 | 135 | 7.199219 | 150 | 42 | 37.5 | 285.6875 | 2.699707 | 2.599609 | 3.099609 | 144 | 7.299805 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,727 | 77.24799 | 1 | female | 1 | 47 | 47 | Lung Cancer | Cancer | 1 | null | under $11k | 9 | 41,185 | 32,064.5625 | null | 8 | white | 12 | 24 | 0.744995 | 0.482971 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | dnr after sadm | 7 | 93 | 18.199219 | 72 | 26 | 37 | null | 4 | 0.699951 | 1.199951 | 134 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,728 | 41.02698 | 1 | male | 1 | 47 | 47 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 18 | >$50k | 0 | 57,856 | 41,057.1875 | null | 10.75 | white | 41.796875 | 58 | 0.459961 | 0.257996 | 1 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 38 | 73 | 15 | 110 | 24 | 37 | null | 2.899902 | 50.695313 | 5 | 135 | null | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
1,729 | 77.96594 | 0 | female | 0 | 16 | 1,937 | COPD | COPD/CHF/Cirrhosis | 3 | 15 | $11-$25k | 9 | 14,553 | 10,891.6562 | null | 15.666664 | white | 21.296875 | 35 | 0.748901 | 0.603882 | 1 | 1 | 0 | no | 0.8 | 0.6 | dnr after sadm | 4 | 95 | 10.298828 | 94 | 28 | 37.79688 | 277.75 | null | null | 2.5 | 142 | 7.429688 | null | null | null | null | 3 | SIP>=30 | 3 |
1,730 | 62.63898 | 1 | male | 0 | 18 | 91 | Lung Cancer | Cancer | 1 | 16 | $11-$25k | 0 | 26,939 | 20,709.8594 | null | 14.666664 | black | 13.199219 | 23 | 0.779907 | 0.539917 | 1 | 0 | 0 | metastatic | 0.8 | 0.3 | dnr after sadm | 7 | 135 | 9.798828 | 48 | 15 | 36.5 | null | 4 | 0.599976 | 1.099854 | 133 | null | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
1,731 | 68.27698 | 1 | male | 0 | 6 | 111 | Colon Cancer | Cancer | 1 | 16 | null | 0 | 5,046 | 3,617.6836 | null | 6 | white | 16 | 28 | 0.823975 | 0.618896 | 1 | 0 | 0 | metastatic | 0.9 | 0.2 | no dnr | 6 | 97 | 20 | 72 | 20 | 37.19531 | null | 3.799805 | 0.399963 | 2.199707 | 136 | null | null | null | null | 2 | 2 | no(M2 and SIP pres) | 2 |
1,732 | 68.64099 | 1 | female | 0 | 19 | 470 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 50,918 | 32,448.8281 | null | 23.333328 | white | 22.398438 | 41 | 0.669922 | 0.574951 | 5 | 0 | 0 | metastatic | 0.6 | 0.3 | no dnr | 19 | 74 | 14.599609 | 117 | 41 | 38.29688 | 415 | null | null | 0.899902 | 146 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,733 | 64.43298 | 1 | male | 1 | 5 | 5 | COPD | COPD/CHF/Cirrhosis | 2 | 20 | null | 9 | 5,135 | 3,777.4356 | null | 12 | white | 24.898438 | 47 | 0.67688 | 0.505981 | 1 | 0 | 0 | metastatic | 0.2 | 0.5 | dnr after sadm | 2 | 115 | 29.898438 | 80 | 40 | 36 | 210 | 3.199707 | null | 0.899902 | 149 | 7.529297 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,734 | 86.65295 | 1 | male | 0 | 7 | 103 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 4,723 | 3,616.1152 | null | 9 | white | 18.296875 | 43 | 0.810913 | 0.69397 | 1 | 0 | 1 | no | 0.9 | 0.8 | no dnr | 7 | 71 | 6.5 | 80 | 42 | 35.79688 | 252.375 | 4 | 1.599854 | 1.699951 | 143 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,735 | 67.409 | 1 | male | 0 | 12 | 1,563 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 9,601 | 7,057.1562 | null | 6 | white | 18.699219 | 19 | 0.834961 | 0.72998 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 12 | 97 | 10.398438 | 69 | 27 | 36 | null | null | null | 1.299805 | 144 | null | null | null | null | null | null | null | 2.505371 |
1,736 | 71.79999 | 1 | male | 0 | 14 | 511 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 21 | null | 0 | 31,459 | 15,559.6328 | null | 17 | white | 22.699219 | 32 | 0.748901 | 0.669922 | 9 | 0 | 0 | no | 0.9 | 0.6 | no dnr | 14 | 53 | 11.898438 | 49 | 24 | 37.39844 | 280.9375 | null | null | 1 | 138 | 7.479492 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,737 | 84.85999 | 1 | male | 0 | 10 | 1,478 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | null | 0 | 8,570 | 6,200.0781 | null | 13 | black | 15.099609 | 22 | 0.822998 | 0.711914 | 1 | 0 | 0 | no | 0.98 | 0.9 | no dnr | 10 | 103 | 14.398438 | 80 | 22 | 37.79688 | null | null | null | 1.399902 | 142 | 7.389648 | null | null | null | 3 | null | no(M2 and SIP pres) | 2.511099 |
1,738 | 76.06 | 1 | male | 1 | 15 | 15 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 35,239 | 11,708.6641 | null | 38.333313 | white | 30.699219 | 36 | 0.601929 | 0.412964 | 1 | 0 | 0 | no | 0.95 | 0.75 | dnr after sadm | 14 | 61 | 9.798828 | 118 | 12 | 38.19531 | 111.65625 | 2.899902 | 1.299805 | 1.599854 | 136 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,739 | 78.672 | 1 | male | 0 | 10 | 1,815 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 10,477 | 5,305.0938 | null | 14.5 | white | 19.296875 | 37 | 0.826904 | 0.767944 | 1 | 1 | 0 | no | 0.9 | 0.8 | dnr after sadm | 1 | 109 | 10.298828 | 111 | 32 | 37.89844 | 420 | 2.799805 | 0.799927 | 0.899902 | 143 | 7.399414 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
1,740 | 30.55199 | 1 | male | 0 | 32 | 304 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 76,135 | 41,028.2812 | null | 22 | black | 21.5 | 29 | 0.896973 | 0.826904 | 1 | 0 | 0 | no | 0.55 | 0.45 | no dnr | 32 | 63 | 15.199219 | 126 | 20 | 38.19531 | 392 | 2.099609 | 3.799805 | 1 | 140 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,741 | 50.396 | 0 | female | 0 | 5 | 1,921 | COPD | COPD/CHF/Cirrhosis | 2 | 5 | null | 0 | 4,530 | 3,147.0176 | null | 6 | black | 25.597656 | 45 | 0.870972 | 0.785889 | 1 | 0 | 0 | no | 0.99 | 0.95 | no dnr | 5 | 51 | 14.398438 | 92 | 24 | 37 | 185.6875 | null | null | 1.299805 | 134 | 7.289062 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
1,742 | 56.00299 | 1 | female | 0 | 8 | 409 | Lung Cancer | Cancer | 2 | 12 | >$50k | 0 | 10,614 | 7,028.1914 | null | 16 | white | 20.296875 | 15 | 0.660889 | 0.358948 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 8 | 116 | 6 | 74 | 28 | 36.69531 | null | 3.299805 | null | 0.599976 | 139 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,743 | 76.33698 | 1 | female | 0 | 13 | 104 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | under $11k | 0 | 9,457 | 6,602.0273 | null | 11.5 | white | 20.296875 | 31 | 0.800903 | 0.679932 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 13 | 87 | 9.599609 | 122 | 36 | 38.5 | 340 | null | null | 0.899902 | 143 | 7.419922 | null | null | null | null | null | no(M2 and SIP pres) | 3.076172 |
1,744 | 59.21399 | 0 | female | 0 | 12 | 1,919 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 33,298 | 22,645.9688 | null | 19 | black | 28.199219 | 37 | 0.725952 | 0.641968 | 4 | 1 | 0 | no | null | null | no dnr | 12 | 105 | 13.5 | 100 | 40 | 38.59375 | 130 | null | null | 1.799805 | 138 | 7.479492 | null | null | null | null | 1 | null | 1 |
1,745 | 66.34595 | 0 | female | 0 | 7 | 1,916 | COPD | COPD/CHF/Cirrhosis | 2 | 11 | null | 0 | 4,751 | 3,376.4043 | null | 9 | white | 17 | 20 | 0.886963 | 0.81189 | 1 | 0 | 0 | no | 0.95 | 0.92 | dnr after sadm | 1 | 97 | 10.5 | 100 | 32 | 36.59375 | 303.3125 | null | null | 1.099854 | 139 | 7.349609 | null | null | null | 6 | 3 | no(M2 and SIP pres) | 3 |
1,746 | 61.48099 | 0 | female | 0 | 25 | 1,916 | CHF | COPD/CHF/Cirrhosis | 2 | 4 | $11-$25k | 0 | 21,507 | 14,395.5781 | null | 12.75 | white | 16.597656 | 41 | 0.900879 | 0.833984 | 1 | 1 | 0 | no | 0.9 | 0.8 | no dnr | 25 | 105 | 8.798828 | 98 | 32 | 37.09375 | 255.53125 | null | null | 1 | 140 | 7.459961 | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 |
1,747 | 63.27399 | 1 | male | 0 | 8 | 1,244 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | $11-$25k | 0 | 7,418 | 4,707.8086 | null | 10 | white | 17.699219 | 27 | 0.825928 | 0.715942 | 1 | 1 | 0 | metastatic | 1 | 0.9 | no dnr | 8 | 63 | 9.199219 | 100 | 25 | 36.59375 | 466.625 | 3.699707 | 1.099854 | 1.299805 | 135 | 7.40918 | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 |
1,748 | 79.64996 | 0 | male | 0 | 6 | 1,915 | COPD | COPD/CHF/Cirrhosis | 2 | 15 | under $11k | 0 | 4,776 | 3,234.5801 | null | 13 | white | 14.599609 | 10 | 0.855957 | 0.762939 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 6 | 85 | 7.299805 | 86 | 20 | 36.79688 | 588.25 | null | null | 0.899902 | 145 | 7.439453 | null | null | null | null | 4 | no(M2 and SIP pres) | 4 |
1,749 | 62.51599 | 1 | female | 0 | 72 | 135 | COPD | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 134,421 | 35,840.0625 | null | 27.5 | black | 19.199219 | 40 | 0.881958 | 0.803955 | 1 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 72 | 143 | 7.199219 | 130 | 32 | 38.19531 | 262.9375 | null | null | 1.199951 | 141 | 7.299805 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,750 | 57.60999 | 1 | male | 0 | 12 | 235 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 14,797 | 9,158.2656 | null | 15.5 | white | 15.199219 | 14 | 0.756958 | 0.501953 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 2 | 81 | 2.799805 | 78 | 22 | 35.69531 | null | null | 0.5 | 1.099854 | 141 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,751 | 85.50598 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 24,531 | 8,586.1094 | null | 26.666656 | white | 27.699219 | 47 | 0.650879 | 0.55188 | 1 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 14 | 107 | 10.599609 | 55 | 44 | 38.19531 | 134.6875 | null | null | 1.899902 | 143 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,752 | 68.29297 | 1 | male | 0 | 6 | 10 | CHF | COPD/CHF/Cirrhosis | 2 | 15 | $11-$25k | 0 | 4,825 | 3,000.5684 | null | 9 | white | 18.898438 | 40 | 0.863892 | 0.774902 | 1 | 1 | 0 | no | 0.95 | 0.75 | no dnr | 6 | 63 | 8.599609 | 61 | 20 | 36.09375 | 319 | 3.699707 | 0.399963 | 2.199707 | 138 | 7.479492 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
1,753 | 88.28699 | 0 | female | 0 | 9 | 1,910 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 7,485 | 4,946.9727 | null | 8 | white | 19.699219 | 27 | 0.727905 | 0.574951 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 9 | 69 | 5.5 | 80 | 14 | 36.09375 | 484 | null | null | 0.699951 | 129 | 7.349609 | null | null | null | 4 | 6 | SIP>=30 | 6 |
1,754 | 80.32898 | 1 | female | 0 | 6 | 77 | Colon Cancer | Cancer | 2 | 10 | null | 0 | 6,066 | 3,936.1367 | null | 14 | white | 20.5 | 45 | 0.727905 | 0.455994 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | dnr after sadm | 1 | 123 | 7.099609 | 60 | 42 | 38.19531 | null | 2.799805 | 0.599976 | 4.099609 | 144 | null | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,755 | 25.92999 | 0 | male | 0 | 9 | 1,909 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | under $11k | 0 | 31,526 | 33,885.3438 | null | 10.5 | white | 30.398438 | 51 | 0.812988 | 0.750977 | 5 | 0 | 0 | no | null | null | no dnr | 9 | 145 | 15.798828 | 120 | 20 | 36.09375 | 136 | null | null | 12.199219 | 135 | 7.199219 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,756 | 85.15796 | 1 | female | 0 | 7 | 41 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 5,272 | 3,606.2617 | null | 6 | white | 24.097656 | 39 | 0.7229 | 0.567993 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 55 | 6.599609 | 62 | 40 | 35.39844 | 428.5625 | null | null | 1.299805 | 138 | 7.489258 | null | null | null | null | null | <2 mo. follow-up | 3.181152 |
1,757 | 40.375 | 0 | male | 0 | 4 | 1,909 | COPD | COPD/CHF/Cirrhosis | 0 | 10 | under $11k | 0 | 3,558 | 1,725.0977 | null | 5 | hispanic | 15.398438 | 10 | 0.957886 | 0.928955 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 83 | 9.898438 | 80 | 20 | 36.69531 | 130 | 4.199219 | 0.399963 | 1 | 143 | 6.969727 | null | null | null | 0 | 1 | SIP>=30 | 1 |
1,758 | 65.53595 | 1 | male | 0 | 50 | 991 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 38,225 | 26,093.1875 | null | 12.25 | white | 21.398438 | 24 | 0.827881 | 0.769897 | 2 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 50 | 53 | 12.398438 | 77 | 24 | 39.29688 | 185.6875 | 2.5 | 0.299988 | 1 | 143 | 7.419922 | null | null | null | 4 | 3 | SIP>=30 | 3 |
1,759 | 59.35098 | 1 | female | 0 | 13 | 57 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 14,557 | 9,539.7266 | null | 10 | white | 25.097656 | 10 | 0.532959 | 0.210999 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 13 | 100 | 6.099609 | 108 | 24 | 36.79688 | null | 2.899902 | 0.299988 | 0.699951 | 145 | null | null | null | null | null | null | <2 mo. follow-up | 3.055176 |
1,760 | 69.95996 | 0 | female | 0 | 23 | 1,907 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 9 | 33,506 | 29,262.4844 | null | 18.666656 | white | 24 | 39 | 0.710938 | 0.622925 | 7 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 23 | 113 | 8.298828 | 63 | 26 | 38.09375 | 175.5 | 2.5 | 0.699951 | 2.599609 | 153 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
1,761 | 83.35394 | 1 | male | 0 | 8 | 100 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | null | 0 | 6,006 | 4,201.6367 | null | 8.5 | white | 17.597656 | 23 | 0.790894 | 0.66394 | 1 | 0 | 0 | yes | 0.9 | 0.5 | no dnr | 8 | 80 | 11.599609 | 68 | 24 | 36.29688 | null | 3.599609 | 0.5 | 1.5 | 134 | null | null | null | null | 0 | 3 | no(M2 and SIP pres) | 3 |
1,762 | 62.17697 | 0 | female | 0 | 5 | 1,907 | CHF | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 5,648 | 3,686.043 | null | 13 | black | 30.398438 | 50 | 0.721924 | 0.566895 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 5 | 63 | 10.398438 | 104 | 28 | 36.79688 | null | 2.099609 | 0.299988 | 2.399902 | 146 | null | null | null | null | 6 | null | no(M2 and SIP pres) | 4.527397 |
1,763 | 64.63196 | 1 | female | 0 | 14 | 33 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 14,478 | 8,823.1172 | null | 19.333328 | white | 41.195313 | 56 | 0.262939 | 0.096985 | 1 | 0 | 0 | metastatic | 0.6 | 0.45 | dnr after sadm | 6 | 43 | 6.599609 | 120 | 38 | 34.79688 | 418.5 | 3.599609 | null | 1.299805 | 126 | 7.489258 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
1,764 | 77.98798 | 1 | female | 1 | 15 | 15 | COPD | COPD/CHF/Cirrhosis | 0 | 12 | under $11k | 0 | 28,654 | 8,108.0273 | null | 33 | white | 27.796875 | 24 | 0.649902 | 0.471985 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 7 | 50 | 9.599609 | 112 | 8 | 38.39844 | 332.5 | 3.199707 | null | 0.5 | 136 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,765 | 25.782 | 0 | male | 0 | 7 | 1,906 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | $25-$50k | 0 | 9,020 | 3,857.5996 | null | 15 | other | 14.599609 | 11 | 0.953979 | 0.93689 | 1 | 0 | 0 | no | 1 | 0.95 | no dnr | 7 | 73 | 5.5 | 76 | 24 | 39.09375 | null | 2.799805 | 0.199982 | 1.299805 | 140 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,766 | 92.95599 | 1 | female | 1 | 11 | 11 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | under $11k | 0 | 16,444 | 5,627.5742 | null | 18.5 | white | 17.398438 | 31 | 0.73291 | 0.581909 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 10 | 68 | 8.599609 | 68 | 24 | 36.79688 | 422.1875 | null | null | 1.799805 | 145 | 7.379883 | null | null | null | 2 | 2 | <2 mo. follow-up | 2 |
1,767 | 81.56897 | 1 | female | 0 | 8 | 396 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $25-$50k | 0 | 6,537 | 4,397.2109 | null | 10.5 | white | 18.199219 | 33 | 0.829956 | 0.7229 | 1 | 0 | 0 | no | 0.99 | 0.98 | no dnr | 8 | 69 | 10.699219 | 78 | 22 | 36.09375 | 252 | null | 0.899902 | 1.699951 | 140 | 7.519531 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
1,768 | 65.06195 | 1 | female | 0 | 5 | 120 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 3,867 | 2,508.041 | null | 6 | white | 24.296875 | 23 | 0.536987 | 0.213989 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 107 | 9.798828 | 98 | 28 | 36.59375 | null | 3.299805 | 0.599976 | 1.199951 | 142 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.242676 |
1,769 | 72.047 | 1 | female | 0 | 10 | 389 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 7,914 | 5,386.832 | null | 8.5 | black | 13.398438 | 22 | 0.849976 | 0.668945 | 1 | 0 | 0 | metastatic | 0.3 | 0.2 | no dnr | 10 | 73 | 2.399902 | 76 | 20 | 37 | null | null | 0.899902 | 0.899902 | 138 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
1,770 | 77.97894 | 1 | female | 0 | 7 | 777 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | null | 0 | 8,999 | 5,357.5039 | null | 16 | white | 30.199219 | 45 | 0.477966 | 0.359985 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 7 | 105 | 17.597656 | 130 | 26 | 36 | 332 | 3.299805 | null | 6.299805 | 137 | 7.429688 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,771 | 70.44995 | 1 | male | 1 | 17 | 17 | Coma | Coma | 2 | 20 | null | 61 | 25,671 | 19,454.9688 | null | 15.333328 | white | 20.296875 | 23 | 0.431946 | 0.357971 | 2 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 2 | 81 | 10.798828 | 104 | 38 | 39 | 345 | null | null | 1.399902 | 139 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,772 | 67.95099 | 1 | female | 1 | 38 | 38 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 33,734 | 22,634.6719 | null | 8.75 | white | 15 | 26 | 0.836914 | 0.642944 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 5 | 73 | 10.199219 | 78 | 16 | 36.5 | null | 3.599609 | 0.399963 | 1.599854 | 137 | null | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
1,773 | 75.33197 | 1 | female | 1 | 60 | 60 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 180,272 | 73,283.0625 | null | 41 | white | 43.195313 | 76 | 0.28894 | 0.178986 | 1 | 0 | 0 | no | null | null | dnr after sadm | 45 | 44 | 43.09375 | 105 | 14 | 36.09375 | 265 | 1.5 | 4.599609 | 7.599609 | 128 | 7.329102 | null | null | null | null | 1 | null | 1 |
1,774 | 76.646 | 1 | female | 0 | 20 | 38 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | >$50k | 26 | 12,745 | 9,543.7656 | null | 6 | white | 18.296875 | 22 | 0.759888 | 0.619995 | 1 | 0 | 1 | no | 0.8 | 0.5 | dnr after sadm | 1 | 84 | 5.299805 | 76 | 30 | 36.59375 | 238.09375 | null | 0.5 | 0.399963 | 144 | 7.379883 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
1,775 | 81.28699 | 1 | male | 0 | 12 | 137 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 26 | 12,674 | 6,361.8516 | null | 17.5 | white | 22.097656 | 33 | 0.69397 | 0.602905 | 1 | 0 | 1 | no | 0.9 | 0.75 | no dnr | 12 | 74 | 10.898438 | 60 | 22 | 36.59375 | 408 | 3.299805 | 0.599976 | 2.5 | 137 | 7.459961 | null | null | null | null | null | null | 5.480469 |
1,776 | 93.91394 | 1 | female | 1 | 7 | 7 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 13,570 | 11,662.1562 | null | 20.5 | white | 32.695313 | 55 | 0.330994 | 0.144989 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 1 | 42 | 13.199219 | 127 | 26 | 38.29688 | 234 | null | null | 1.399902 | 140 | 7.269531 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,777 | 80.72296 | 1 | female | 0 | 8 | 108 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 9 | 7,633 | 4,950.8477 | null | 15 | white | 24.898438 | 56 | 0.654907 | 0.477966 | 1 | 0 | 1 | no | 0.8 | 0.7 | dnr after sadm | 1 | 112 | 7 | 160 | 28 | 38.19531 | 161.65625 | 4.099609 | null | 2.599609 | 141 | 7.089844 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
1,778 | 60.35599 | 1 | male | 1 | 9 | 9 | Colon Cancer | Cancer | 1 | null | null | 0 | 13,863 | 8,505.2422 | null | 16 | white | 59 | 82 | 0.003 | 0 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 3 | 49 | 8.199219 | 130 | 36 | 35.09375 | null | 2.399902 | 20.199219 | 2.799805 | 137 | null | null | null | null | null | null | <2 mo. follow-up | 2.29541 |
1,779 | 60.34497 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | $11-$25k | 0 | 86,807 | 67,231.1875 | null | 36 | white | 28.199219 | 37 | 0.700928 | 0.610962 | 8 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 18 | 51 | 11.599609 | 102 | 8 | 38.79688 | 168 | null | null | 1.299805 | 147 | 7.259766 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
1,780 | 93.77399 | 1 | female | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 15,581 | 6,194.3398 | null | 23.5 | white | 31.5 | 44 | 0.501953 | 0.384949 | 1 | 0 | 1 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 50 | 3.899902 | 60 | 25 | 36.69531 | 155 | 3 | 0.299988 | 0.899902 | 145 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 5.107422 |
1,781 | 70.82794 | 1 | female | 0 | 13 | 321 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 14,896 | 7,133.4609 | null | 22 | white | 30.398438 | 41 | 0.451965 | 0.332947 | 1 | 0 | 0 | metastatic | 0.2 | 0.04 | dnr after sadm | 2 | 56 | 14.298828 | 102 | 40 | 38.09375 | 114 | 2.799805 | 0.599976 | 0.599976 | 138 | 7.429688 | null | null | null | null | null | null | 2.492676 |
1,782 | 69.76898 | 1 | female | 1 | 9 | 9 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 9,542 | 6,106.1094 | null | 15.5 | white | 30.796875 | 41 | 0.33197 | 0.064987 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 2 | 70 | 67.296875 | 116 | 38 | 36.79688 | 338.0625 | 2.899902 | 0.399963 | 0.899902 | 143 | 7.459961 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
1,783 | 46.349 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 100,904 | 64,948.5938 | null | 50 | white | 40.09375 | 73 | 0.455994 | 0.336975 | 23 | 0 | 0 | no | null | null | dnr after sadm | 8 | 57 | 23.796875 | 102 | 12 | 37 | 268.3125 | 2.399902 | 39.296875 | 3.899902 | 138 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.762207 |
1,784 | 61.14697 | 1 | female | 0 | 12 | 161 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 23,298 | 13,658.8594 | null | 21 | white | 22.699219 | 42 | 0.784912 | 0.714966 | 4 | 1 | 0 | no | null | null | no dnr | 12 | 120 | 11 | 62 | 30 | 38 | 234.6875 | 3 | null | 6.199219 | 140 | 7.319336 | null | null | null | null | null | null | 2.272949 |
1,785 | 51.13998 | 0 | male | 0 | 6 | 1,890 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 6 | under $11k | 0 | 7,438 | 2,830.9902 | null | 15 | white | 15.398438 | 21 | 0.921997 | 0.892944 | 1 | 0 | 0 | no | 0.98 | 0.97 | no dnr | 6 | 63 | 7.099609 | 75 | 28 | 36.39844 | 256 | null | 0.5 | 0.899902 | 139 | 7.459961 | null | null | null | 2 | 0 | adl>=4 (>=5 if sur) | 0 |
1,786 | 59.69598 | 1 | male | 0 | 30 | 122 | Colon Cancer | Cancer | 2 | null | null | 0 | 40,846 | 25,642.7969 | null | 10.75 | white | 13.699219 | 22 | 0.863892 | 0.696899 | 1 | 0 | 0 | metastatic | null | null | no dnr | 30 | 56 | 8 | 80 | 15 | 36.69531 | null | 3.699707 | 0.399963 | 1.099854 | 145 | null | null | null | null | null | null | null | 2.358887 |
1,787 | 73.31995 | 0 | female | 0 | 25 | 1,887 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 28,079 | 14,801.8203 | null | 12.333328 | white | 23.597656 | 33 | 0.784912 | 0.714966 | 1 | 0 | 0 | no | 1 | 0.95 | no dnr | 25 | 99 | 10.099609 | 102 | 42 | 38.09375 | 144.875 | 2.5 | 0.5 | 0.799927 | 142 | 7.419922 | null | null | null | null | null | null | 2.424805 |
1,788 | 35.76199 | 0 | male | 0 | 12 | 1,886 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | $11-$25k | 0 | 14,027 | 6,408.0898 | null | 21.5 | white | 23.199219 | 25 | 0.891968 | 0.853882 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 12 | 53 | 14.5 | 106 | 22 | 38 | 212.21875 | 2.299805 | 1.5 | 1.099854 | 138 | 7.469727 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
1,789 | 77.35797 | 1 | female | 0 | 19 | 896 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 28,820 | 13,814.8125 | null | 21.666656 | white | 42.695313 | 57 | 0.243988 | 0.085999 | 1 | 1 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 37 | 10.5 | 92 | 40 | 37.59375 | 170 | 2.5 | 0.399963 | 1.099854 | 153 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 3.270996 |
1,790 | 83.57794 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 0 | null | 37 | 65,318 | 51,210.2188 | null | 47 | white | 37.898438 | 72 | 0.058998 | 0.019997 | 15 | 0 | 0 | yes | null | null | dnr after sadm | 11 | 67 | 19.199219 | 130 | 34 | 38.79688 | 74 | 1.799805 | null | 2.799805 | 133 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
1,791 | 82.80096 | 1 | female | 0 | 20 | 368 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 35,464 | 29,197.8125 | null | 19.666656 | white | 23.097656 | 32 | 0.755981 | 0.677979 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 20 | 64 | 13.5 | 54 | 24 | 37.39844 | 190 | null | null | 1.699951 | 134 | 7.439453 | null | null | null | 0 | null | null | 0.4948 |
1,792 | 58.82498 | 1 | male | 0 | 5 | 1,625 | Lung Cancer | Cancer | 1 | 12 | under $11k | 0 | 5,670 | 3,605.0137 | null | 15 | black | 10.5 | 13 | 0.824951 | 0.620972 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 5 | 103 | 3.399902 | 64 | 20 | 36.59375 | null | 3.799805 | 0.199982 | 1 | 141 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,793 | 77.56097 | 0 | female | 0 | 7 | 1,883 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 5,333 | 3,607.3574 | null | 13 | hispanic | 16.597656 | 22 | 0.827881 | 0.718994 | 1 | 0 | 0 | yes | 0.95 | 0.95 | no dnr | 7 | 107 | 7.799805 | 78 | 24 | 35.79688 | null | null | 0.899902 | 1.399902 | 137 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
1,794 | 53.70297 | 1 | female | 0 | 47 | 1,794 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 91,986 | 72,924.0625 | null | 34.25 | white | 25.796875 | 36 | 0.796997 | 0.72998 | 3 | 1 | 0 | no | 0.7 | 0.65 | no dnr | 47 | 65 | 18.296875 | 150 | 10 | 38.29688 | 164 | null | null | 0.599976 | 137 | 7.509766 | null | null | null | null | 1 | SIP>=30 | 1 |
1,795 | 78.43695 | 1 | female | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 2 | 14 | $25-$50k | 0 | 17,635 | 6,980.957 | null | 40 | white | 39.195313 | 61 | 0.18399 | 0.095993 | 1 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 5 | 49 | 1.399902 | 140 | 24 | 39 | 138 | 1.799805 | 1.599854 | 1.099854 | 144 | 7.319336 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,796 | 52.68997 | 1 | male | 0 | 10 | 858 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | $25-$50k | 0 | 11,201 | 6,830.2617 | null | 13.5 | white | 23.597656 | 32 | 0.880981 | 0.800903 | 1 | 0 | 0 | no | 0.99 | 0.9 | no dnr | 10 | 110 | 13.099609 | 120 | 30 | 36.69531 | 192.84375 | null | 0.699951 | 0.899902 | 137 | 7.389648 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
1,797 | 44.30399 | 1 | female | 1 | 21 | 21 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | null | 9 | 56,112 | 21,248.1875 | null | 30 | black | 25.699219 | 38 | 0.767944 | 0.630981 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 20 | 59 | 12.398438 | 139 | 21 | 39.09375 | 432 | 3.299805 | 5.899414 | 0.899902 | 138 | 7.40918 | null | null | null | 7 | 0 | <2 mo. follow-up | 0 |
1,798 | 82.09399 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | under $11k | 0 | 15,079 | 5,353.8984 | null | 54 | white | 75.890625 | 96 | 0 | 0 | 2 | 1 | 0 | no | 0 | 0 | dnr after sadm | 5 | 0 | 11.5 | 0 | 0 | 35.59375 | 306 | null | 0.699951 | 2.299805 | 135 | 7.269531 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
1,799 | 44.48199 | 0 | female | 0 | 7 | 1,880 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 13,559 | 6,085.4531 | null | 20 | white | 27.699219 | 26 | 0.816895 | 0.702881 | 3 | 0 | 0 | no | 0.75 | 0.4 | no dnr | 7 | 51 | 10.5 | 122 | 20 | 37 | 352.375 | null | null | 0.599976 | 135 | 7.469727 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
1,800 | 75.086 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 0 | 38,936 | 31,189.4219 | null | 35.333313 | white | 31.398438 | 34 | 0.416992 | 0.296997 | 3 | 0 | 0 | metastatic | 0.5 | 0.05 | dnr after sadm | 14 | 55 | 13.199219 | 118 | 12 | 38.5 | 101.42188 | null | null | 0.699951 | 141 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.